IP vs NVCR · P/E 43, $26.62B cap vs rev $605.2M
International Paper (IP) versus Novocure Ltd (NVCR) — a side-by-side from cached financials, not a winner call.
International Paper (IP) is a packaging & containers company listed on US.
Novocure Ltd (NVCR) is a medical devices company listed on US.
IP does not have a complete income-statement cache yet.
Latest reported NVCR revenue for 2024-12-31 was $605.2M. Net income was -$168.6M. Revenue was up 18.8% from 2023-12-31 to 2024-12-31. NVCR currently screens at market cap $1.99B.
IP currently screens at market cap $26.62B and trailing P/E 43.1. NVCR currently screens at market cap $1.99B.
Not investment advice. Open the IP and NVCR stock pages for the full models.
Not investment advice.